Health

AI-powered cardiac imaging company HeartFlow sued its competitor Cleerly this week, claiming the company infringed on its patents and misused proprietary technology to build a competing platform. The lawsuit, filed …

The journey of a Travere Therapeutics drug has culminated in a long-awaited FDA approval, making the once-daily pill the first therapy for a rare disease that, in severe cases, leads …

Medical device innovation is laborious because of the high bar for validating that the technology does no harm. Patient recruitment for statistically powered trials stretches timelines and drives validation costs …

Enrollment in Medicare Advantage has steadily increased over the past two decades. The number of MA enrollees grew from about 11 million (25% of total Medicare beneficiaries) in 2010 to …

Hospitals’ financial positioning is somewhat stable but still under significant pressure, mainly from rising costs and reimbursement issues, according to data released last week by Kaufman Hall. The consulting firm …

A Revolution Medicines drug helped patients pancreatic cancer live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in …

In life sciences, AI usually makes headlines for drug discovery, molecule design or clinical insights. Behind the scenes, though, the fastest and most repeatable wins are showing up in FDA-oriented …

As a practicing emergency physician, I appreciate watching HBO’s The Pitt, because it offers a reasonably realistic depiction of what it’s like to work on the front lines of today’s …

To some, President Donald Trump’s budget proposal might be adding an insult to an injury. Last year, the federal government made significant cuts to healthcare coverage in Medicaid via the …

Antibody drug conjugates bring a targeted approach to the treatment of many types of cancer, but there’s still room for improving this class of therapies. This week, two startups revealed …